From the Guidelines
Vitamin B12 supplementation is indicated for individuals with a confirmed deficiency, particularly those with severe deficiency or neurological symptoms. The treatment options include oral cyanocobalamin (100-1000 mcg daily) or intramuscular methylcobalamin (1000 mcg every 1-3 months) 1.
Key Indications for Supplementation
- Confirmed vitamin B12 deficiency
- Severe deficiency or neurological symptoms, such as unexplained sensory and/or motor and gait symptoms
- Pernicious anemia or other chronic conditions
- Patients undergoing bariatric surgery or with a history of ileal resection
- Individuals with inflammatory bowel disease, such as Crohn's disease
Treatment Regimens
- For patients with neurological involvement, initial treatment with hydroxocobalamin 1 mg intramuscularly on alternate days until there is no further improvement, then administer hydroxocobalamin 1 mg intramuscularly every 2 months 1
- For patients with no neurological involvement, hydroxocobalamin 1 mg intramuscularly three times a week for 2 weeks, followed by maintenance treatment with 1 mg intramuscularly every 2–3 months for life 1
- Oral vitamin B12 supplementation may be effective, but parenteral supplementation is often necessary for patients with severe deficiency or malabsorption 1
Important Considerations
- Lifelong treatment may be required for patients with pernicious anemia or other chronic conditions 1
- Regular monitoring of vitamin B12 levels and adjustment of treatment regimens as needed is crucial to prevent complications and ensure optimal outcomes 1
- Vitamin B12 deficiency can be masked by folic acid supplementation, emphasizing the importance of diagnosing and treating vitamin B12 deficiency promptly 1
From the FDA Drug Label
Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency The indications for Vitamin B12 (Cobalamin) supplementation are:
- Vitamin B12 deficiencies due to:
- Addisonian (pernicious) anemia
- Gastrointestinal pathology, dysfunction, or surgery
- Gluten enteropathy or sprue
- Small bowel bacteria overgrowth
- Total or partial gastrectomy
- Fish tapeworm infestation
- Malignancy of pancreas or bowel
- Folic acid deficiency Requirements of vitamin B12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral supplementation 2
From the Research
Indications for Vitamin B12 Supplementation
The following are indications for Vitamin B12 supplementation:
- Reduced dietary intake of B12, which requires oral supplementation 3
- B12 malabsorption, where oral supplementation is likely insufficient and parenteral (intramuscular) supplementation is preferred 3
- Pernicious anemia, where oral vitamin B12 supplementation has been shown to be effective in improving vitamin B12 deficiency 4, 5, 6
- Protein malabsorption, where daily oral cyanocobalamin can be used for treatment 5
- Vitamin B12-deficient anemia, where oral vitamin B12 supplementation can be used as an alternative to intramuscular injections 7
Patient Groups that May Benefit from Supplementation
Certain patient groups may benefit from Vitamin B12 supplementation, including:
- Older adults, as cobalamin-deficient anemia is common in this population 5
- Patients with severe neurologic involvement, although there is limited evidence to support the use of oral cyanocobalamin replacement in these cases 5
- Patients with hyperhomocysteinemia, as vitamin B12 deficiency has been implicated in the promotion of atherosclerosis 6
Effective Dosages and Administration
Effective dosages and administration of Vitamin B12 supplementation include:
- Oral cyanocobalamin at doses of 1000-2000 microg daily 5, 7
- High oral doses of B12 (1000 mcg and 2000 mcg) as effective as intramuscular administration in achieving haematological and neurological responses 7
- Parenteral (intramuscular) supplementation with 1000 µg hydroxocobalamin once every two months after the initial loading, as recommended by the British National Formulary guidelines 3